Deletion of haematopoietic Dectin-2 or CARD9 does not protect from atherosclerosis development under hyperglycaemic conditions
Author(s) -
Kathrin Thiem,
Geerte Hoeke,
Enchen Zhou,
Anneke Hijmans,
Tom Houben,
Margien G. S. Boels,
Isabel M. Mol,
Esther Lutgens,
Ronit ShiriSverdlov,
Johan Bussink,
ThirumalaDevi Kanneganti,
Mariëtte R. Boon,
Rinke Stienstra,
Cees J. Tack,
Patrick C.N. Rensen,
Mihai G. Netea,
Jimmy F.P. Berbée,
Janna A. van Diepen
Publication year - 2019
Publication title -
diabetes and vascular disease research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.965
H-Index - 54
eISSN - 1752-8984
pISSN - 1479-1641
DOI - 10.1177/1479164119892140
Subject(s) - haematopoiesis , immune system , inflammation , biology , receptor , immunology , macrophage , cytokine , bone marrow , proinflammatory cytokine , pattern recognition receptor , lesion , endocrinology , medicine , immunity , microbiology and biotechnology , stem cell , in vitro , biochemistry , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom